PhaseBio Pharmaceuticals, Inc.
METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS
Last updated:
Abstract:
The present disclosure provides a method of treating muscle myopathy, including muscle dystrophies and cardiomyopathies, by administering stable, long-lasting vasoactive intestinal peptide therapeutic agents. These agents include one or more clastin-like peptides and can be administered at a low-dose.
Status:
Application
Type:
Utility
Filling date:
22 Jun 2020
Issue date:
11 Mar 2021